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Introduction
In vertebrates, the spleen is a lymphoid organ that serves
important roles in hematopoiesis and the generation of primary
immune responses, as well as acting as a filter that removes
and processes aged and abnormal blood cells (VanRooijen et
al., 1989; Zapata and Cooper, 1990). During development, the
spleen originates from splanchnic mesoderm (mesenchyme
that surrounds the gut endoderm), which arises from splitting
of the lateral plate mesoderm into somatic mesoderm (body
wall) and splanchnic mesoderm (Funayama et al., 1999). The
latter undergoes gut-specific mesodermal differentiation
(Apelqvist et al., 1997; Ramalho-Santos et al., 2000) in
response to signals from the endoderm that gives rise to the
epithelium of the gut and associated organs. Histological
studies using frog, chick and mammalian embryos indicate
that development of the splenic anlage is first detectable at
approximately gestational day (E) 11, as progenitor cells
derived from splanchnic mesoderm form a single condensation
within the dorsal mesogastrium (Dm; the mesenchymal sheet
that attaches the stomach to the dorsal body wall), adjacent to
the stomach and dorsal pancreas (Thiel and Downey, 1921;
Manning and Horton, 1969; Sty and Conway, 1985; Vellguth
et al., 1985; Yassine et al., 1989).
In vertebrates, the mesodermally derived spleen normally
displays left-handed asymmetry (Boorman and Shimeld, 2002)
and has been considered to be a landmark organ for detecting
laterality defects (Aylsworth, 2001). But, interestingly, mice
with left-right (LR) asymmetry defects, such as the Inv/Inv
(Yokoyama et al., 1993) and ActRIIB (Oh et al., 2002) mutant
mice exhibit either normally developed spleens or,
infrequently, splenic hypoplasia. Furthermore, asplenic mouse
models, such as the Dh spontaneous mutant (Green, 1967) and
the Nkx3.2 (Bapx1 – Mouse Genome Informatics) mutant
mouse (Lettice et al., 1999; Tribioli et al., 1999), appear to
exhibit only regional perturbations of LR asymmetry in the
primordial splenopancreatic mesoderm (Hecksher-Sorensen et
al., 2004). Other asplenic mouse models, such as those mutant
for Hox11 (Tlx1 – Mouse Genome Informatics) (Roberts et al.,
1994; Dear et al., 1995), display asplenia as the sole organ
abnormality. Likewise, in humans, asplenia may present as the
sole organ anomaly, without perturbations of LR asymmetry
The genetic control of cell fate specification, morphogenesis
and expansion of the spleen, a crucial lymphoid organ, is
poorly understood. Recent studies of mutant mice implicate
various transcription factors in spleen development, but the
hierarchical relationships between these factors have not
been explored. In this report, we establish a genetic
network that regulates spleen ontogeny, by analyzing
asplenic mice mutant for the transcription factors Pbx1,
Hox11 (Tlx1), Nkx3.2 (Bapx1) and Pod1 (capsulin, Tcf21).
We show that Hox11 and Nkx2.5, among the earliest known
markers for splenic progenitor cells, are absent in the
splenic anlage of Pbx1 homozygous mutant (–/–) embryos,
implicating the TALE homeoprotein Pbx1 in splenic
cell specification. Pbx1 and Hox11 genetically interact in
spleen formation and loss of either is associated with a
similar reduction of progenitor cell proliferation and
failed expansion of the splenic anlage. Chromatin
immunoprecipitation assays show that Pbx1 binds to the
Hox11 promoter in spleen mesenchymal cells, which co-
express Pbx1 and Hox11. Furthermore, Hox11 binds its
own promoter in vivo and acts synergistically with TALE
proteins to activate transcription, supporting its role in an
auto-regulatory circuit. These studies establish a Pbx1-
Hox11-dependent genetic and transcriptional pathway in
spleen ontogeny. Additionally, we demonstrate that while
Nkx3.2 and Pod1 control spleen development via separate
pathways, Pbx1 genetically regulates key players in both
pathways, and thus emerges as a central hierarchical co-
regulator in spleen genesis.
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(Rose et al., 1975; Waldman et al., 1977). Overall, these
findings underscore the notion that, both in mice and humans,
mechanisms other than the regulation of LR asymmetry must
be responsible for the control of splenic cell fate specification
and morphogenesis.
Recent advances in mouse genetics have led to the discovery
of novel genes required for early spleen ontogeny. These
include Hox11 (Roberts et al., 1994; Dear et al., 1995; Kanzler
and Dear, 2001), Nkx3.2 (Lettice et al., 1999; Tribioli et al.,
1999), Pod1 (Quaggin et al., 1999; Lu et al., 2000) and Wt1
(Herzer et al., 1999); however, the hierarchical relationships
among these genes remain unknown. This limited collection of
genes also includes Pbx1 (Nourse et al., 1990; Kamps et al.,
1990), which encodes a TALE class (Burglin, 1997)
homeodomain protein, the absence of which results in
embryonic asplenia with 100% penetrance (Selleri et al., 2001).
Although the role of Pbx1 in spleen development is undefined,
its reported biochemical in vitro interaction with homeodomain
protein Hox11 through the hexapeptide motif (Shen et al., 1996)
raises the possibility that these two homeoproteins may
cooperate in spleen ontogeny, as Hox11 is also required for
spleen formation (Roberts et al., 1994; Dear et al., 1995).
Heterodimers of Pbx and other TALE proteins of the Meinox
family, such as Meis (Bischof et al., 1998; Chang et al., 1997)
and Pknox/Prep1 (Berthelsen et al., 1998; Knoepfler et al.,
1997; Fognani et al., 2002), form stable nuclear complexes, and
biochemical analyses suggest that these complexes regulate
several genes (Swift et al., 1998). Indeed, we have found that
loss of Pbx1 causes multiple organogenesis defects in the
mouse and lethality in utero at E15.5 (Selleri et al., 2001).
These defects include abnormalities in patterning and
development of the skeleton (Selleri et al., 2001), in pancreas
morphogenesis and function (Kim and Selleri et al., 2002), in
adrenal/urogenital development (Schnabel et al., 2003a;
Schnabel et al., 2003b), and in caudal pharyngeal pouch-
derived organ formation and patterning (Manley and Selleri et
al., 2004), as well as impaired hematopoiesis (DiMartino and
Selleri et al., 2001). These findings underscore the notion that
Pbx1 serves as a key developmental regulator, although the
crucial genetic and transcriptional pathways underlying its
specific developmental roles have not been established.
In this report, we investigated spleen ontogeny by analyzing
asplenic mouse models lacking Pbx1, Hox11, Nkx3.2 or Pod1
(capsulin). Our studies define a genetic hierarchy in which
Pbx1 serves a central and crucial role as a common co-
regulator in spleen ontogeny.
Materials and methods
Mice
Asplenic knockout mice for Hox11 (Roberts et al., 1994), Hox11lacZ
(lacZ insertion into the Hox11 locus) (Dear et al., 1995), Pbx1 (Selleri
et al., 2001) and Pod1 (Quaggin et al., 1999) have been described and
were genotyped according to previously published protocols. Nkx3.2
(Bapx1) asplenic knockout mice were generated and kindly provided
by Drs W. Zimmer and R. Schwartz (unpublished). Pbx2 knockout
mice, which develop normally, were genotyped as described
previously (Selleri et al., 2004).
Histological analysis, immunohistochemistry and in situ
hybridization
Embryos from E10.5 to E15.5 were harvested and fixed overnight
at 4°C in phosphate-buffered saline (PBS) containing 4% (w/v)
paraformaldehyde (PFA). For histological analysis and
immunohistochemistry with a mouse anti-Pbx1b primary antibody
(Jacobs et al., 1999), protocols were followed as described (Selleri et
al., 2001). Single-stranded sense and antisense riboprobes for in situ
hybridization on frozen sections were specific for Hox11 (Dear et al.,
1995), Nkx3.2 (Tribioli et al., 1997), Nkx2.5 (Lyons et al., 1995), Pbx1
(3′ UTR), Pod1 (Quaggin et al., 1998) and Wt1 (Herzer et al., 1999).
Assessment of β-galactosidase activity
Embryos heterozygous for Hox11lacZ were collected at E11.5 and
E12.5 and stained for β-galactosidase as described previously (Dear
et al., 1995).
Staining of germinal centers
Mice 6-8 weeks old were immunized by intravenous (i.v.) injection
of 5107 sheep red blood cells (SRBC) in PBS. Mice were sacrificed
and the spleens processed for immunohistochemistry with
biotinylated lectin peanut agglutinin (PNA; Vector Laboratories,
Burlingame, CA) as described (Inada et al., 1998).
BrdU analysis
Pregnant Pbx1+/– and Hox11+/– female mice, carrying embryos at
E12.5 and E13.5, respectively, were injected intraperitoneally with 5-
bromo-2-deoxy-uridine (BrdU) (50 µg/g of body weight) and BrdU
incorporation was assayed as previously described (Selleri et al.,
2001). The number of BrdU-positive cells (dark brown nuclei) within
the developing spleen were counted in six to eight sagittal sections
(10 µm thickness) for each genotype. Quantitative analysis of BrdU
immunoperoxidase-stained sections was made on a Nikon microscope
equipped with a video camera. TUNEL assays were performed as
described by Gavrieli et al. (Gavrieli et al., 1992).
Cell culture and immunostaining
Embryonic spleens at day E16-17 were dissected and trypsinized
(0.25% final concentration) for 10-15 minutes at 37°C. The cell
suspension was washed twice and cultured in Dulbecco’s Modified
Eagle Medium (D-MEM), supplemented with 10% fetal calf serum
(Celbio), 2 mM L-glutamine (Invitrogen), 100 U/ml penicillin and 100
mg/ml streptomycin (Invitrogen) in humidified 5% CO2, and used as
a primary cell culture for chromatin immunoprecipitation (ChIP)
assays. Primary spleen cultures were immunophenotyped by using an
α-smooth muscle actin Ab (ASMA; Santa Cruz Biotech), which stains
mesoderm-derived cells. To generate immortalized spleen embryonic
cell lines from Pbx2–/– embryos, the NIH 3T3 protocol (Todaro et al.,
1963) was used.
Western blot analysis
Western blot analysis was performed as described previously
(Berthelsen et al., 1996; Jacobs et al., 1999). The following antibodies
were used: anti-Hox11 (1:1,000) (Santa Cruz Biotech, CA), anti-
Pbx1b (1:1,500) (Jacobs et al., 1999) and anti-Prep 1 (1:1,500;
Upstate Biotechnology).
In vitro transcription assays
NIH 3T3 cells were cultured in D-MEM supplemented with 5% fetal
calf serum and 5% delipidated fetal calf serum. Transient transfections
were performed using Lipofectamine 2000 (Invitrogen) according to
the manufacturer’s instructions. For Hox11 promoter analysis, the
following constructs were used: a luciferase reporter vector (pGL2);
a pGL2 construct carrying an EcoRI-SalI 0.9 kb fragment,
corresponding to the Hox11 promoter region (pGL2-540) (Arai et al.,
1997); pcDNA3 constructs containing the cDNA of Pbx1a or Prep1
(Berthelsen et al., 1998) and a pBlueScript-Hox11 construct
containing the full-length cDNA of Hox11 (obtained from Dr N.
Hoehler) (Koehler et al., 2000). Cells were lysed 40-45 hours after
transfection and assayed for luciferase activity (Benasciutti et al.,
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2004). Values were normalized for β-gal activity. Data
represent means of triplicate values from a representative
experiment. All transfections were independently performed
three times.
Electrophoretic mobility shift assays
Electrophoretic mobility shift assays (EMSA) were performed
as described (Berthelsen et al., 1996; Jacobs et al., 1999) using
nuclear extracts from spleen cells. The following
oligonucleotides, spanning Pbx1-binding sites within the
Hox11 promoter (AB 000681) (Arai et al., 1997), were
employed in EMSA reactions: 5′-CCAAAGGCTTGTGA-
CTGCTTTTCAGG-3′ PX1 and 5′-CCAAAGGCTTGTCG-
ACGCTTTTCAGG-3′ PX1 mutated.
The following antibodies were used: rabbit polyclonal
antibodies specific for Pbx1 (P-20) and Hox11 (C-18; Santa
Cruz Biotech, CA).
Chromatin immunoprecipitation assay
Formaldehyde crosslinking and chromatin
immunoprecipitation were performed as described (Frank et
al., 2001). Samples were immunoprecipitated overnight at 4°C
with the following antibodies: mouse monoclonal specific for
Pbx1b (Jacobs et al., 1999), rabbit polyclonal specific for
Hox11 (Santa Cruz Biotech, CA), mouse monoclonal anti-
Green Fluorescent Protein (anti-GFP; Santa Cruz Biotech, CA)
and normal rabbit serum (Covenge Research). Immune
complexes were recovered by adding 30 µl of blocked protein
G beads and incubated for 2 hours at 4°C. Beads were washed
and eluted, and crosslinks were reversed as described (Aparicio
et al., 1999). The eluted DNA was resuspended in 30-60 µl
water. A region within the Hox11 promoter containing the
Pbx1-binding sites (–359 s/–115 as and –258 s/–54 as) and a
control region within the same promoter (–1170 s/–891 as)
were amplified by PCR using specific primer pairs. One primer
pair that amplifies a region of the Bmp4 promoter was also used
as additional negative control: 5′-ACGCACTTCCCTGA-
TTCTCGTC-3′ (–359 s) and 5′-AGCAGTCACAAGCCTT-
TGGATTAC-3′ (–115 as) product size 244 bp; 5′-
TCTCACAAACCCAGAGCCATTC-3′ (–258 s) and 5′-TAG-
CAGCCACTCCAACTCAGTCTC-3′ (–54 as) product size
204 bp; 5′-TGAGAACAACTACCTGCTTCGTGC-3′ (–1170
s) and 5′-TGGAGACTTGACTTGCCCAACC-3′ (–891 as)
product size 279 bp; and 5′-AATGAACAAACACCACT-
CTCCCTC (Bmp4 s) and 5′-AACACCAGACCGAAAAGAT-
GACTG (Bmp4 as) product size 350 bp.
Results
Loss of Pbx1 causes agenesis of the spleen
Analysis of Pbx1–/– embryos at E15.5 demonstrated that
they are asplenic (Fig. 1B,D), compared with wild-type
controls, which exhibited a fully developed ribbon-
shaped spleen (Fig. 1A,C). The defect in spleen development
was evident at E13.5 because of the absence of the splenic
anlage (Fig. 1F), which is easily recognizable in close
proximity to the stomach on histological sections of wild-type
embryos (Fig. 1E). Earlier in development, at E11-12.5,
histological and in situ analyses (Fig. 2) indicated that the
splenic primordium, which starts to be recognizable as a
condensation of mesenchymal cells within the normal Dm,
lateral to the stomach (Thiel and Downey, 1921), was
hypoplastic in Pbx1–/– embryos (Fig. 2). At even earlier stages
of organogenesis (E10-10.5), however, the differentiation of
the splanchnic mesoderm into the epithelial-like plate of cells
that is well distinguished from the surrounding unorganized
mesenchyme (Green, 1967), was completely preserved in
Pbx1–/– embryos (Fig. 1G-J). In fact, at this developmental
stage, the general architecture of the splanchnic mesoderm that
surrounds the stomach enlargement (Fig. 1G-J) and midgut
primordia (not shown) within the coelomic cavity did not
appear morphologically abnormal in Pbx1–/– embryos. This
contrasts with other cases of murine asplenia, which exhibit
marked abnormalities of the splanchnic mesoderm, such as that
documented in the Dh mutant, which lacks the epithelial-like
plate of cells at E10-10.5 (Green, 1967; Hecksher-Sorensen et
al., 2004).
Fig. 1. Agenesis of the spleen in Pbx1–/– embryos. (A,B) Comparative whole-
mount preparation of upper abdominal organs at E15.5 shows the lack of a
spleen, together with liver hypoplasia, in Pbx1–/– embryos (B). The spleen
forms lateral to the stomach, and appears as a reddish ribbon-shaped organ in
wild-type embryos (black dashes in A). (C,D) Histology of Hematoxylin and
Eosin-stained transverse sections at E15.5 show agenesis of the spleen in
Pbx1–/– embryos compared with wild-type littermates. (E,F) Histology of
Hematoxylin and Eosin-stained transverse sections of E13.5 wild-type and
Pbx1–/– embryos. A visible spleen primordium forms as a mesenchymal
condensation within the dorsal mesogastrium (Dm, arrows) in wild-type
embryos (E). In Pbx1–/– littermates (F), no mesenchymal condensation is
detectable within the Dm (arrowheads). (G-J) Histology of Hematoxylin-
stained transverse sections of wild-type and Pbx1–/– embryos in the region of
the stomach enlargement at E10-10.5. The splanchnic mesoderm lateral to
the stomach enlargement (G,I) consists of a thick epithelial-like plate of cells
(arrows) that encloses unorganized mesenchyme. The black boxes indicate
the regions magnified (40) in H,J, which highlight the organized epithelial-
like cellular structure of the splanchnic mesoderm. C, coelomic cavity; Dm,
dorsal mesogastrium; L, liver; Sp, spleen; St, stomach.
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Pbx1 is required for onset of Hox11 (Tlx1) and
Nkx2.5 gene expression in the splenic anlage
Visualization of gene transcripts known to be present in the
condensing splenic mesenchyme within the Dm was conducted
to trace spleen ontogeny at early embryonic stages (E11-12.5)
and to establish hierarchical requirements for specific
transcription factors in splenic cell fate specification and
morphogenesis. Using in situ hybridization, we assessed
expression of Hox11 (Koehler et al., 2000; Kanzler and Dear
2001) (Fig. 2A-D) and Nkx2.5 (Patterson et al., 2000;
Hecksher-Sorensen et al., 2004), which are first observed in
Dm mesenchyme between E10.5 and E11 and are regarded as
the earliest known markers for splenic cell fate.
By E11, Nkx2.5 is normally detectable in a domain of the
murine Dm (Figs 2 and 3) that overlaps with the expression of
Hox11, lateral to the stomach (Hecksher-Sorensen et al., 2004).
In Pbx1–/– embryos, however, Hox11 and Nkx2.5 were absent
in the condensing splenic mesenchyme of the Dm from E11 to
E12.5 (Hox11, Fig. 2A-D; Nkx2.5, Fig. 3K,L; analysis of
Nkx2.5 at E11-11.5 is not shown). Hox11 expression was not
detected up to E13.5 by in situ hybridization in Dm condensing
splenic mesenchyme of Pbx1–/– embryos (not shown),
indicating a complete absence of Hox11, rather than a temporal
delay of its expression in the spleen anlage. Thus, Hox11
expression is completely absent in splenic condensing
mesenchyme and later in the spleen anlage. Conversely, Hox11
expression was unperturbed in other organ primordia, such as
the developing pancreas at E12.5 and the branchial arches (not
shown). By contrast, no alterations of Pbx1 expression were
observed in the Dm splenic condensing mesenchyme of
Hox11–/– embryos (Fig. 3A,B). Taken together, these results
indicate that the onset and continued expression of Hox11 in
the splenic anlage, unlike in non-splenic domains, is Pbx1
dependent, whereas Pbx1 expression is not dependent on the
Development 132 (13) Research article
Fig. 2. Perturbed expression of Hox11 and Wt1, known regulators of spleen development, in Pbx1–/– embryos. Transcripts for the spleen
regulators Hox11, Wt1, Pod1 and Nkx3.2 were detected by in situ hybridization to frozen sagittal sections of wild-type and Pbx1–/– upper
abdominal organs at E11-11.5 and E12-12.5, as indicated. The splenic primordium is outlined by black dashes. (A-D) Both at E11-11.5 and
E12-12.5 Hox11 expression is absent in the spleen primordia of Pbx1–/– embryos, compared with wild-type littermates. (E-H) Wt1 expression is
also absent in spleen anlage of Pbx1–/– embryos compared with wild-type littermates both at E11-11.5 and E12-12.5. It is noteworthy that Wt1
expression is still present in the mesothelial lining that surrounds the mesenchyme of the splenic anlage (arrow). (I-L) Pod1 and (M-P) Nkx3.2
are normally expressed within the developing spleen primordia of Pbx1–/– embryos compared with wild-type littermates, both at E11-11.5 and
E12-12.5. L, liver; Sp, spleen; St, stomach.
D
ev
el
op
m
en
t
3117Pbx1 regulation of spleen development
presence of Hox11 protein. Furthermore, our findings also
suggest that, in the absence of Pbx1, splenic cell fate
specification is, at least in part, compromised, as two of the
earliest known markers of splenic cell fate, Nkx2.5 and Hox11,
are absent in Dm condensing mesenchyme. Conversely,
expression of other genes that mark splenic condensing
mesenchyme, such as Pod1 (Fig. 2I-L) and Nkx3.2 (Fig. 2M-
P) is maintained in Pbx1–/– embryos, demonstrating that
condensing mesenchymal cells are still present in Dm of
Pbx1–/– embryos and that splenic gene expression is not
globally impaired by Pbx1 loss.
Pbx1 regulates Wt1 gene expression in splenic
condensing mesenchymal cells, but not in the outer
mesothelial lining
Wt1 is expressed during early spleen development in the
mouse (Rackely et al., 1993) and is required for spleen
development (Herzer et al., 1999). It is normally expressed in
a domain of the Dm that, by E11, overlaps with that of Hox11
within the splenic condensing mesenchyme lateral to the
stomach (Fig. 2E,G). Wt1 is regulated by Hox11 in spleen
development, as its expression is diminished in Hox11–/–
embryos (Koehler, 2000) (data not shown). In addition, Wt1,
like Pbx1, is highly expressed in the outer mesothelial lining
of the splenic anlage (Fig. 2E,G) that will give rise to the
splenic capsule (Sadler, 1995). By contrast, Hox11 is not
expressed in the mesothelial lining of the developing spleen
(Fig. 4A, arrowhead).
Expression of Wt1 was severely down regulated in the
condensing mesenchyme of Pbx1–/– Dm, when compared
with wild-type littermates. However, its expression was well
maintained in the outer mesothelial lining of the Pbx1–/–
splenic primordium, both at E11-11.5 and E12-12.5 (Fig. 2E-
H). As Hox11 is absent in Pbx1–/– embryos, and Wt1 is
regulated by Hox11 (Koehler, 2000) (data not shown), these
findings suggest a genetic hierarchy whereby Pbx1 regulates
Hox11, which in turn regulates Wt1 in condensing splenic
mesenchyme. Nevertheless, while Wt1 expression in Dm
splenic mesenchyme is hierarchically dependent upon Pbx1,
probably through Hox11, its expression is independent of Pbx1
in the developing splenic capsule.
Pbx1 and Pod1 independently regulate Nkx2.5 in the
splenic anlage
Expression of Pod1 (Robb et al., 1998; Lu et al., 2000) (Fig.
2I-L) and Nkx3.2 (Fig. 2M-P) overlaps with Hox11 and Nkx2.5
in the condensing splenic mesenchyme. In addition, gene
targeting studies have shown that Pod1 (Quaggin et al., 1999;
Lu et al., 2000) and Nkx3.2 (Lettice et al., 1999; Tribioli et al.,
1999) are required for spleen development. Pod1 (Fig. 2I-L)
and Nkx3.2 (Fig. 2M-P) expression is maintained in Pbx1–/–
embryos, and Pbx1 expression is unperturbed in the
Fig. 3. Analysis of Pbx1 and Nkx2.5 gene expression during early spleen organogenesis. In situ hybridization was performed on frozen sagittal
sections of E12-12.5 embryonic upper abdominal organs. (A-F) Normal expression of Pbx1 within the developing splenic anlage of Hox11–/–,
Pod1–/– and Nkx3.2–/– embryos. (G-L) Perturbed expression of Nkx2.5 in Pod1–/– and Pbx1–/– embryos. Nkx2.5 expression is unperturbed in the
developing splenic anlage of Hox11–/– embryos (H), while it is absent in Pod1–/– (J) and Pbx1–/– (L) embryos, compared with their wild-type
littermates (G,I,K). L, liver; Sp, spleen; St, stomach.
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condensing mesenchyme of both Pod1–/– (Fig. 3C,D) and
Nkx3.2–/– (Fig. 3E,F) embryos at E12-12.5. Thus, Pbx1
expression in Dm condensing mesenchyme is not dependent
on the presence of either Pod1 or Nkx3.2. We also confirm that
Nkx3.2 is expressed in the condensing mesenchyme of Pod1–/–
embryos at E12-12.5 (see Fig. S1A,B in the supplementary
material), as already reported by others (Lu et al., 2000).
Additionally, Pod1–/– expression is unperturbed in Nkx3.2–/–
embryos at E12-12.5 (see Fig. S1C,D in the supplementary
material). Thus, the Pod1 and Nkx3.2 pathways appear to be
separate in early spleen development. Furthermore, our present
studies (Fig. 2A-D) and work by Lettice et al. (Lettice et al.,
1999) reveal that Pbx1 and Nkx3.2 independently regulate
Hox11 in a hierarchical fashion. Therefore, Hox11 expression
is dependent on both Pbx1 (Fig. 2A-D) and Nkx3.2 (Lettice et
al., 1999). Moreover, no expression of Nkx2.5 was observed in
the condensing splenic mesenchyme of Pod1–/– or Pbx1–/–
embryos (Fig. 3I,J; K,L). Conversely, we demonstrated that
Nkx2.5 is still expressed in the condensing splenic
mesenchyme of Nkx3.2–/– embryos (see Fig. S1E,F in the
supplementary material) at E12-12.5. Thus, Nkx2.5 expression
is dependent on both Pbx1 (Fig. 3K,L) and Pod1 (Fig. 3I,J),
although it is not dependent on Nkx3.2 (see Fig. S1E,F in the
supplementary material). Taken together, these results suggest
that Pbx1 impinges on the control of the separate Pod1 and
Nkx3.2 pathways, both essential for spleen development, by
functioning upstream of Hox11 and Nkx2.5, respectively.
Genetic interaction of Pbx1 and Hox11 during
spleen organogenesis
Given the dependence of Hox11 expression on Pbx1, the
potential colocalization of these two transcription factors was
assessed in splenic mesenchymal cells. Sections from E11.5
and E12.5 Hox11lacZ/+ embryos (in which the lacZ gene was
inserted into the Hox11 locus) (Dear et al., 1995) were
immunostained with an anti-Pbx1b monoclonal antibody
(Jacobs et al., 1999) and simultaneously stained for β-
galactosidase activity. In these mice, lacZ expression faithfully
recapitulates expression of Hox11 in the splenic anlage
(Kanzler and Dear, 2001). Pbx1 (visualized by brown staining)
and Hox11 (visualized by blue staining) were present and
colocalized (Fig. 4B,D; arrow) in cells of the condensing
splenic mesenchyme. However, not all Pbx1-positive cells
expressed Hox11 (Fig. 4B,D; arrowhead), which was notably
absent in the thickened mesothelial lining that surrounds the
mesenchyme of the splenic anlage (Fig. 4A,C; arrowhead).
Given the requirement for both Hox11 (Roberts et al., 1994;
Dear et al., 1995) and Pbx1 in spleen development and their
cellular colocalization in the splenic anlage, their potential
genetic interaction during spleen ontogeny was assessed.
Pbx1+/– and Hox11+/– mice were intercrossed and offspring
were examined at 6 to 8 weeks of age (Table 1). A high
percentage (80%) of Pbx1+/–;Hox11+/– double heterozygous
mice displayed hypoplastic and malformed spleens, compared
with wild-type or single heterozygous littermates (Fig. 4E,F;
Table 1), of which a very low percentage exhibited splenic
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Fig. 4. Genetic interaction of Pbx1 and Hox11 during spleen
organogenesis. (A-D) Immunostaining of sagittal sections of E11.5
(A,B) and E 12.5 (C,D) Hox11lacZ/+ embryonic upper abdominal
organs. Arrowheads in A-D indicate cells expressing Pbx1 but not
Hox11. Pbx1 is visualized in the splenic anlage with DAB (brown
staining), and Hox11 by β-galactosidase staining (blue).
(B,D) Enlargements of the black rectangle depicted on the splenic
anlage in A,C. Arrows in B,D indicate cells in which Pbx1 and
Hox11 colocalize. (E,F) The spectrum of malformations of double
heterozygous spleens (F) is compared with the normal gross
morphology of Pbx1+/– spleens (E). The Pbx1+/–;Hox11+/– double
heterozygous spleens are hypoplastic (F), and display sickle shapes,
indentations, tubercles and nodules, as well as fusions of two spleens
(arrowheads). All spleens were isolated from 6- to 8-week-old mice.
(G,H) Hematoxylin and Eosin-stained spleen sections reveal no
abnormalities in splenic structure of Pbx1+/–;Hox11+/– double
heterozygous mice. Distribution of white (arrows) and red
(arrowheads) pulp is normal within the spleen parenchyma of double
heterozygous mice (H) compared with Pbx1+/– (not shown), Hox11+/–
(not shown) and wild-type (G) littermates. (I,J) PNA-stained spleen
sections of mice immunized with sheep red blood cells (SRBC).
Formation of germinal centers (GC; arrows), as indicated by PNA
staining (brown), appears normal in Pbx1+/–;Hox11+/– double
heterozygous mice (J) compared with Pbx1+/– (not shown), Hox11+/–
(not shown) and wild-type (I) littermate controls. L, liver; Sp, spleen;
St, stomach.
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morphological abnormalities such as minor
indentations (Table 1). The spectrum of malformations
of double heterozygous spleens (Fig. 4F) comprised
sickle shapes, presence of indentations, tubercles and
nodules, as well as fusions of two spleens
(polysplenia). Thus, Pbx1 and Hox11 genetically
interact in spleen development. Despite the observed
morphological abnormalities, Pbx1+/–;Hox11+/– double
heterozygous mice exhibited normal splenic
architecture (Fig. 4G,H), germinal center (GC) (Dent
et al., 1997) formation (Fig. 4I,J) and primary immune
function (not shown).
Mesenchymal cell proliferation is similarly
impaired in the splenic anlage of embryos that
lack Pbx1 or Hox11
Early expansion of the splenic anlage, prior to
hematopoietic invasion at E14.5 (Sasaki and
Matsumura, 1988), is dependent primarily on
proliferation of splenic mesenchymal progenitor cells.
Evaluation of mesenchymal cell proliferation by BrdU
in vivo labeling showed a marked reduction in the
percentage of S-phase cells in Pbx1–/– splenic
mesenchyme compared with wild-type controls at
E13.5 (Fig. 5A,B). No significant reduction of S-phase
cells in Pbx1–/– splenic mesenchyme was found at E12.5
(not shown). Conversely, no detectable increase of
apoptosis was found in Pbx1–/– splenic mesenchyme by
TUNEL assay (Gavrieli et al., 1992), either at E12.5 or
at E13.5 (not shown). Taken together, these results
indicate that although loss of Pbx1 does not affect
mesenchymal cell survival, by E13.5 it severely affects
cell proliferation and, therefore, expansion of the
splenic anlage.
Given the in vivo genetic interaction of Pbx1 and
Hox11 in spleen development and their cellular
colocalization, BrdU in vivo labeling was also
performed in E13.5 Hox11–/– embryos. The splenic
anlage of Hox11–/– embryos (Fig. 5C,D) was
remarkably similar to that of Pbx1–/– embryos (Fig.
5A,B), with a reduction in the percentage of S-phase
cells of ~50% in both mutants. Interestingly, the splenic
primordium of E13.5 Hox11–/– embryos, unlike that of
Pbx1–/– embryos, also exhibited a modest increase in
apoptosis, mostly localized to the mesothelium
surrounding the mesenchyme of the splenic primordium
(not shown). In sum, loss of either Pbx1 or Hox11
presents a comparable phenotype, affecting the
Fig. 5. Similar reduction of spleen progenitor cell proliferation in Pbx1–/–
and Hox11–/– embryos. (A,C) BrdU in vivo labeling of sagittal sections of
upper abdominal organs shows a striking difference in the percentage of
BrdU-positive nuclei (brown) within the spleen anlage of Pbx1–/– and
Hox11–/– embryos, compared with wild-type littermates at E13.5. (B,D)
Proliferation of spleen mesenchymal progenitors is reduced by ~50% in
Pbx1–/– and Hox11–/– embryos, respectively, when compared with wild-type
littermates. The results are expressed as total BrdU-positive cells per mm2 of
spleen anlage. Data are mean±s.e.m. of four E 13.5 embryos analyzed for
each genotype. Black bars, wild type; grey bars, Pbx1–/– and Hox11–/–
embryos; Sp, spleen; St, stomach.
Table 1. Genetic interaction of Pbx1 and Hox11 in vivo during spleen organogenesis
Spleen phenotype
Pbx1–/–; Hox11
wild type
Pbx1 wild
type; Hox11–/–
Pbx1 wild type;
Hox11 wild type
Pbx1+/–; Hox11
wild type
Pbx1 wild type;
Hox11+/– Pbx1+/–; Hox11+/–
Asplenia 100% 100% 0% 0% 0% 0%
Spleen malformations 4%
Indentations
9%
Indentations
6%
Indentations
80%
Sickle form,
indentations,
tubercles, nodules,
protuberances, fusion
of two spleens
Percentage of mice exhibiting the indicated spleen phenotype. Data are from 30-60 mice (6 to 8 weeks old) of each genotype.
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proliferation of mesenchymal splenic progenitor cells and
preventing normal expansion of the splenic anlage.
Hox11 is a direct in vivo target of Pbx1 in spleen
ontogeny
To investigate the possibility that Pbx1 may directly regulate
Hox11 expression, sequences of the Hox11 promoter that are
conserved between the mouse and human genes were
examined for Pbx-binding sites. A potential Pbx-binding site
(PX1) was identified within the 540 bp Hox11 region that
displays promoter activity (Arai et al., 1997), as indicated in
Fig. 6A. To determine if the PX1 element could support the
formation of a Pbx1 DNA-binding complex, EMSA assays
were performed using nuclear extracts from primary
embryonic spleen cells. A slow-migrating band containing
Pbx1, as demonstrated by its specific competition with
an anti-Pbx1 antibody, was observed to form on an
oligonucleotide containing the PX1 site (Fig. 6B: left panel,
lanes 1 and 2).
Hox11 was also present in this DNA-binding complex, as
indicated by the finding that an anti-Hox11 antibody inhibited
complex formation (Fig. 6B: right panel, lane 2). The complex
was not observed to form on a PX1 oligo mutated within the
Pbx1 site (mPX1) (Fig. 6B: middle panel, lane 1), confirming
the specificity of Pbx1-Hox11 binding. Additionally, complex
formation was inhibited by excess unlabeled wild-type PX1
oligo, but not by its mutated form mPX1 (not shown), further
confirming binding specificity. These results demonstrate that
an endogenous Pbx1-Hox11 heterodimer assembles on the
PX1 site of the Hox11 promoter in vitro.
Possible in vivo Hox11 promoter-specific binding by Pbx1
and Hox11 was examined by chromatin immunoprecipitation
(ChIP) performed on primary cell cultures established from
murine embryonic spleens at E16. These primary murine spleen
Development 132 (13) Research article
Fig. 6. Recruitment of Pbx1 and
Hox11 to the mouse Hox11 promoter.
(A) Schematic illustration of 1.2 kb
of the Hox11 genomic segment with
known promoter activity that
contains Pbx1-binding sites, and a 5′
upstream region. Primers used for
PCR analysis are indicated by arrows
(each pair in a different color) and
the oligoprobe (PX1) used for EMSA
is indicated by a black box.
(B) Binding of Pbx1 and Hox11 to
the (PX1) oligo within the Hox11
promoter. Nuclear extracts derived
from wild-type primary embryonic
spleen cells were subjected to EMSA
with a radiolabeled PX1 probe
containing a Pbx1 wild-type (PX1) or
mutated (mPX1) core binding site
(underlined), as indicated above gel
lanes. Asterisk indicates non-specific
band. (C) Primary cells isolated from
embryonic spleen stained in culture
for the mesodermal marker α smooth
muscle actin (green fluorescence).
Western blot analysis (panel below)
demonstrates that these cells produce
Pbx1, Prep1 and Hox11 proteins.
Two isoforms of Hox11 are present
in embryonic spleen, as indicated
(Yamamoto et al., 1995). (D,E) For
ChIP analysis, chromatin was
subjected to immunoprecipitation
(IP) using antibodies specific for
Pbx1b (anti-Pbx1b) (D) or Hox11
(anti-Hox11) (E). As negative
controls, IPs were also performed
with an anti-GFP antibody, rabbit
serum (RS) or no antibody (No Ab).
A primer pair that amplifies a region
within the Bmp4 promoter was used
as an additional negative control. (F) Synergistic activation of the Hox11 promoter by Pbx1, Prep1 and Hox11 proteins. Luciferase activity was
assayed from transiently transfected NIH 3T3 cells. Co-transfection assays were performed in the presence (+) of the indicated expression
vectors encoding Pbx1, Prep1 or Hox11, and with a vector containing the promoter regulatory region of Hox11 (p540), or with vector alone (p-
GL2). Data are expressed as the fold activation over the p540 basal luciferase activity. Bars represent the mean of three independent
transfections (performed in duplicate)±s.e.m. normalized for β-galactosidase activity (internal control) within each experiment.
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cultures, which uniformly expressed the mesodermal marker
alpha-smooth muscle actin (green fluorescence; Fig. 6C: top
panel), exhibited high levels of Pbx1b, Hox11 and the Meinox
co-factor protein Prep1, as detected by western blot analysis
(Fig. 6C: bottom panel). The binding of Pbx1 and Hox11 was
examined at the region of the Hox11 promoter (Arai et al., 1997;
Fig. 6A) that contains the PX1 site, where assembly of the
Pbx1-Hox11 heterodimer had been detected by EMSA. Two
different pairs of primers within this region (spanning regions
–258 to –54, depicted in red, and –359 to –115, depicted in teal)
amplified sequences within the Hox11 promoter that had been
immunoprecipitated by the anti-Pbx1b antibody (Fig. 6D: left
and middle panels). As a control for Pbx1b antibody specificity,
two different sets of primers (one on the Hox11 promoter:
–1170 to –891; depicted in blue; and one on the Bmp4
promoter) did not amplify their respective intervening
sequences after immunoprecipitation (Fig. 6D: right panel).
The potential binding of Hox11 at its own promoter in vivo
in embryonic murine spleen cells was also examined by ChIP
assay. Similar to Pbx1, Hox11 was present at the region of
Hox11 promoter activity (Fig. 6E), as detected by both primer
pairs that revealed Pbx1 on the Hox11 promoter (Fig. 6E: left
panel and data not shown). Overall, these results indicate
recruitment of both Pbx1 and Hox11 on the Hox11 promoter in
vivo in spleen embryonic cells. Thus, Hox11 is a direct target
of Pbx1. The simultaneous binding of Hox11 to its own
promoter suggests that it may contribute to an auto-regulatory
circuit in spleen development.
Hox11 autoregulates its own promoter with Pbx1
The functional consequences of potential interactions of Pbx1
and Hox11 for Hox11 expression were tested in transient
transcription assays using NIH 3T3 fibroblasts. For these
studies, we employed a luciferase reporter construct containing
the promoter regulatory region of Hox11 (p540) (Arai et al.,
1997), which spans the PX1 site. When the p540 reporter gene
was co-transfected with the Pbx1 construct no activation above
background was observed (Fig. 6F). Co-expression of Pbx1 and
a representative Meinox family protein, Prep1 (highly
expressed in spleen mesenchyme; Fig. 6C: bottom panel),
resulted in transcriptional activation of two- to threefold above
background levels (Fig. 6F). Significantly, co-transfection of
Hox11 with Pbx1 and Prep1 resulted in an eight- to ninefold
increase in transcription above the baseline (Fig. 6F). These
results demonstrate that synergistic activation of the Hox11
promoter is achieved by the association of the three
homeodomain proteins, consistent with a Pbx1-dependent auto-
regulatory role for Hox11 to enhance and/or maintain its own
expression during spleen development.
Discussion
In this report we investigated the genetic and transcriptional
control of cell fate specification, morphogenesis and expansion
of the spleen, using various asplenic mouse models. Our results
establish a genetic network that regulates spleen ontogeny and
is dependent upon Pbx1, which encodes a TALE class
homeodomain protein that serves a reiterative role in early
splenic morphogenesis as well as later anlage expansion. A
crucial part of the Pbx1 role in spleen development is due to
its genetic and transcriptional interaction with Hox11, which
autoregulates its own promoter with Pbx1 in spleen progenitor
cells. However, Pbx1 genetically regulates key genes
downstream of both Nkx3.2 and Pod1, which we demonstrate
to control spleen development via separate pathways. These
results reveal a broad and crucial role for Pbx1 as a central
hierarchical co-regulator in spleen genesis.
Loss of Pbx1 does not affect LR decisions or
development of the splanchnic mesoderm
Regional perturbations of LR asymmetry have been associated
with spleen agenesis in Dh spontaneous mutants and Nkx3.2–/–
embryos (Hecksher-Sorensen et al., 2004). However, our
studies demonstrate that asplenia in Pbx1–/– embryos is not the
result of perturbations of LR asymmetry, providing further
evidence that asplenia is not always associated with LR
asymmetry defects. This notion is best supported by the
presence of spleen agenesis as the sole organ abnormality,
without perturbations of LR asymmetry, in mice that lack Pod1
(Quaggin et al., 1999) or Hox11 (Roberts et al., 1994; Dear
et al., 1995) (N. Dear, personal communication). Similarly,
Pbx1–/– embryos do not exhibit anomalies of LR asymmetry
in the heart (C. P. Chang, unpublished), lungs (B. Hogan,
personal communication), liver or stomach (data not shown).
Although the Pbx1–/– pancreas displays an anteroposterior
(AP) patterning defect, it does not present LR asymmetry
abnormalities (Kim and Selleri et al., 2002).
Furthermore, at E10-10.5, the architecture of the splanchnic
mesoderm, which normally exhibits an epithelial-like cellular
organization, remains well preserved in Pbx1–/– embryos. This
contrasts with Dh mutant embryos, in which the splanchnic
mesoderm is replaced by unorganized mesenchyme, and
Nkx3.2–/– embryos, in which it is in part defective (Green, 1967;
Hecksher-Sorensen et al., 2004). Thus, loss of Pbx1 does not
result in perturbations of very early developmental choices, such
as LR position and differentiation of the splanchnic mesoderm.
Reiterative requirement for Pbx1 in early splenic
morphogenesis and later anlage expansion
In vertebrates Pbx1 is a key developmental regulator required
for the ontogeny of most organ systems (Selleri et al., 2001).
In this study, we demonstrate that Pbx1 is reiteratively required
in spleen development. First, it affects, at least in part, the fate
of condensing mesenchymal cells during early organogenesis,
at E11-11.5, as demonstrated by the absence of Nkx2.5 and
Hox11 in Pbx1–/– Dm. Therefore, Pbx1 genetically regulates
both Hox11 and Nkx2.5 in early spleen morphogenesis. Nkx2.5
is regarded as one of the earliest known markers for spleen
progenitor cells (Patterson et al., 2000), and its expression
overlaps with Hox11, although its requirement in spleen
genesis has not yet been shown since Nkx2.5 loss causes
lethality in utero at E9-10, before development of the splenic
anlage (Lyons et al., 1995). Second, at later stages of
organogenesis, by E13.5, Pbx1 is required again for splenic
progenitor cell proliferation, as detected by BrdU incorporation
experiments, underscoring the essential role of Pbx1 in organ
expansion. Thus, Pbx1 exhibits temporally distinct roles in
spleen ontogeny, reminiscent of its dual contributions to
skeletal development (Selleri et al., 2001).
Regulation of another marker of early splenic anlage, Wt1,
is also dependent on Pbx1, possibly through regulation of
Hox11, in the splenic condensing mesenchyme. It is of interest
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that regulation of Wt1 expression is independent of Pbx1 in the
outer mesothelial lining of the splenic anlage, which normally
does not express Hox11, and will give rise to the splenic
capsule. Taken together, these results support a scenario where
Pbx1 regulates Hox11, which in turn regulates Wt1 in the
splenic mesenchyme, whereas in the mesothelial lining of the
developing spleen regulation of Wt1 is uncoupled from Pbx1.
Thus, Pbx1 can be considered as the uppermost known genetic
regulator within the Hox11-Wt1 pathway in the non-
mesothelial splenic mesenchyme (Fig. 7A).
Expression of other genes that mark early condensing
splenic mesenchyme, such as Pod1 and Nkx3.2, is well
maintained in Pbx1–/– embryos, demonstrating that splenic
condensing mesenchymal cells are still present in Dm of
Pbx1–/– embryos and splenic gene expression is not globally
impaired by Pbx1 loss. Thus, requirement for Pod1 and
Nkx3.2 in spleen ontogeny is not dependent upon Pbx1.
Finally, the findings by Lu et al. (Lu et al., 2000), confirmed
by our present studies, that Nkx3.2 is expressed in the
condensing mesenchyme of Pod1–/– embryos at E12-12.5, and
our results that Pod1–/– expression is unperturbed in Nkx3.2–/–
embryos, indicate that the Pod1 and Nkx3.2 transcription
factors use separate pathways to regulate early spleen
development.
Although previous work has demonstrated asplenia in
Hox11 mutants (Roberts et al., 1994; Dear et al., 1995), until
now the cellular basis of this defect was mostly unknown.
Indeed, apoptosis was not detected in Hox11–/– splenic
primordium in a previous study (Roberts et al., 1995), while it
was documented in another report that used a different Hox11-
deficient model (Dear et al., 1995). In the present study, we
observed a modest increase of apoptosis in Hox11–/– splenic
primordium. The apoptotic cells were mostly localized to the
outer mesothelial lining of the splenic anlage, which gives rise
to the spleen capsule and does not normally express Hox11.
Thus, it appears that such a subtle increase of apoptosis cannot
be responsible for the complete lack of spleen development in
Hox11-deficient embryos. Conversely, our finding that, by
E13.5, Hox11–/– spleen progenitor cells exhibit a marked
defect in cellular proliferation comparable with that in
Pbx1–/– embryos is consistent with the hypoplasia of
Hox11–/– splenic anlage (Roberts et al., 1994; Dear et al.,
1995) and the demonstrated involvement of Hox11 in
cellular proliferation and cell cycle control (Kawabe et
al., 1997; Hough et al., 1998; Owens et al., 2003).
Finally, the finding of a common cellular defect (i.e.
impaired progenitor cell proliferation) in spleen development
of Pbx1–/– and Hox11–/– embryos further corroborates the
observation that Pbx1 genetically regulates Hox11.
In sum, the requirement for Pbx1 in spleen ontogeny appears
to be reiterative. This reiterative role can account for the
complete absence of the spleen, which would not otherwise be
explained either by a partial impairment of splenic cell fate
specification or by a 50% decrease in progenitor cellular
proliferation in the splenic anlage, but probably results from
the summation of these defects.
Genetic interaction of Pbx1 and Hox11 in spleen
ontogeny
The finding of a high percentage (80%) of Pbx1+/–;Hox11+/–
double heterozygous mice displaying severely hypoplastic and
malformed spleens (Fig. 4E,F; Table 1), compared with single
heterozygotes, demonstrates that Pbx1 and Hox11 genetically
interact in vivo in spleen development. The wide spectrum of
malformations of Pbx1+/–;Hox11+/– double heterozygous
spleens, which includes fusions of two spleens, mimics
polysplenia, a human congenital condition. In polysplenia two
or more splenic masses, hypoplastic and irregularly shaped
(splenules), are present lateral to the stomach (Lodewyk et al.,
1972). Unlike human asplenia, which involves life-threatening
infections in children (Waldman et al., 1977), polysplenia
is associated with normal splenic function (Lodewyk et
al., 1972). Despite their morphological abnormalities,
Pbx1+/–;Hox11+/– double heterozygous mice exhibit normal
splenic architecture, germinal center formation and primary
immune function (not shown), thus closely modeling the
human polysplenic condition.
Hox11 is a direct in vivo target of Pbx1 and auto-
regulates its own promoter with Pbx1 in spleen
ontogeny
Despite the growing understanding of Hox and TALE
homeoprotein functions in development (Krumlauf, 1994;
Mann and Affolter, 1998; Popperl et al., 2000; Selleri et al.,
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Fig. 7. Pbx1-dependent genetic network and transcriptional
pathway regulate spleen ontogeny. (A) Transverse section of
abdominal organs schematically illustrates the location of the
spleen primordium during vertebrate development. Adapted,
with permission, from Sadler (Sadler, 1995). To the right, the
Pbx1-Hox11 transcriptional hierarchy regulating spleen
ontogeny is depicted, with the Pbx1-dependent pathway in
red. The Nkx2.5 downstream pathway is illustrated with a
broken arrow as the requirement for Nkx2.5, an early marker
of splenic progenitor cells, has not yet been demonstrated in
spleen development. (B) Within the Pbx1-Hox11
transcriptional pathway, Pbx1 directly regulates Hox11 in
spleen progenitor cells and Hox11, in turn, regulates its own
promoter together with Pbx1.
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2001; Waskiewicz et al., 2002; Hisa et al., 2004; Selleri et al.,
2004) and their functional interactions (Popperl et al., 1995;
Maconochie et al., 1997; Jacobs et al., 1999; Ferretti et al.,
2000; Manzanares et al., 2001; Samad et al., 2004), to date,
only a few direct target genes have been reported (Rauskolb et
al., 1993; Graba et al., 1997; Bromleigh and Freedman, 2000;
Theokli et al., 2003). In this study, we provide the first in vivo
evidence that Pbx1 directly regulates Hox11 in embryonic
spleen cells. Interestingly, at E9.5, Pbx1 is already expressed
in the mid-gut mesenchyme (Schnabel et al., 2001), from
which the spleen is derived, well before the onset of Hox11
expression (Kanzler and Dear, 2001). And indeed, Pbx1
controls the onset of Hox11 expression at E11 within the Dm,
as demonstrated by our in situ hybridization experiments.
Although Pbx1 expression starts to decrease in the splenic
anlage after E13.5 (data not shown), Hox11 persists in the
spleen until birth (Kanzler and Dear, 2001), suggesting that
Pbx1 is required for the onset of Hox11 expression and for its
continued expression in early spleen development, until E13.5,
although it is not necessary for Hox11 maintenance in later
phases of organogenesis.
Hox11 is one of the earliest known markers for spleen cell
progenitors (Dear et al., 1995). A useful tool to monitor Hox11
transcription in the developing spleen is provided by Hox11lacZ
mice (Dear et al., 1995), in which lacZ expression is dependent
on Hox11 regulatory sequences and faithfully recapitulates
Hox11 expression. Analysis of Hox11lacZ/lacZ embryos
previously demonstrated that lacZ expression is normally
initiated in the absence of Hox11 (Dear et al., 1995), suggesting
that the Hox11 protein is not required for initiation of its own
transcription in the splenic mesenchyme. These findings
indicate that other factors might be necessary for the onset of
Hox11 transcription. Here, we identify Pbx1 as one such factor
that activates Hox11 transcriptional onset and early expression
in the splenic anlage until E 13.5.
Pbx1 and Hox11 bind to a potential Pbx-binding site (PX1)
within the Hox11 promoter, as shown by EMSA assays
conducted on embryonic spleen primary cells. Additionally,
Pbx1 and Hox11 bind the Hox11 promoter in vivo in
embryonic spleen cells, as revealed by ChIP assays. Regulatory
interactions of Hox genes, such as the induction of Hoxb1
segmental expression by Hoxb1 and Hoxa1 through auto-
and cross-regulatory loops, have been documented in
developmental processes (Popperl et al., 1995; Studer et al.,
1996; Studer et al., 1998). Here, we reveal an autoregulatory
loop for an orphan Hox gene, Hox11, which is non-clustered
but bears a hexapeptide motif (Shen et al., 1996). Taken
together, our findings establish that Hox11 is a direct target of
Pbx1 and that, simultaneously, it regulates its own promoter.
Significantly, co-transfection of Hox11 with Pbx1 and
Prep1 resulted in a striking increase in transcription above
baseline, demonstrating that synergistic activation of the
Hox11 promoter is achieved by the association of the
three homeoproteins, consistent with a Pbx1-dependent
autoregulatory role for Hox11 to enhance and/or maintain, at
least in part, its own expression during spleen development.
Interestingly, additional potential Pbx-Meinox-binding sites
were identified within the Hox11 promoter downstream of the
PX1 site (not shown), suggesting that multiple binding sites
within close proximity might be used, simultaneously or at
different times, for a complex, multi-faceted transcriptional
regulation of Hox11 in spleen development.
Establishment of a Pbx1-dependent genetic and
transcriptional network that regulates spleen
ontogeny
In addition to establishing that Pbx1 is the most upstream
known direct regulator of Hox11 in spleen ontogeny (Fig. 7A),
our studies demonstrate an even broader role for Pbx1 in spleen
development. Pbx1 regulates key genes downstream of Nkx3.2
and Pod1, which we show to control spleen development
through separate genetic pathways (Fig. 7A). Both Nkx3.2
(Lettice et al., 1999; Tribioli et al., 1999) and Pod1 (Quaggin
et al., 1999; Lu et al., 2000) are essential for spleen
development, and their expression in condensing splenic
mesenchyme overlaps with Hox11 and Nkx2.5. The specific
mechanisms and cellular behaviors by which the Nkx3.2
transcription factor regulates spleen development are as yet
unknown, while Pod1 has been proposed to control splenic cell
survival (Lu et al., 2000). Interestingly, Lu et al. have reported
that the spleen primordium of Pod1–/– embryos does not further
expand after E12.5 and starts to undergo apoptotic cell death.
As a result, after E12.5, expression of all splenic markers,
including Nkx3.2, disappears from the degenerating splenic
primordium of Pod1–/– embryos (Lu et al., 2000). Our studies
demonstrate that Pbx1 expression is not dependent on the
presence of either Nkx3.2 or Pod1 in the splenic mesenchyme
(Fig. 7A). Likewise, the requirement for both of these
transcription factors in splenic development is Pbx1
independent (Fig. 7A). In addition, our findings that Nkx3.2 is
expressed in the condensing mesenchyme of Pod1–/– embryos
at E12-12.5, and that Pod1 expression is also unperturbed in
Nkx3.2–/– embryos, indicate that the Pod1 and Nkx3.2
transcription factors use separate pathways to regulate early
spleen development.
Furthermore, our studies reveal that Pbx1 and Nkx3.2
independently regulate Hox11 in a hierarchical fashion (Fig.
2M-P; Fig. 3E,F) (Lettice et al., 1999). And, in a similar
scenario, Pbx1 and Pod1, but not Nkx3.2 (see Fig. S1E,F),
independently control Nkx2.5 gene expression in a hierarchical
fashion (Fig. 7A). Thus, Pbx1 impinges on the separate Nkx3.2
and Pod1 pathways by genetically regulating key players in
both of these pathways, i.e. Hox11 and Nkx2.5 (Fig. 7A). As a
result, Pbx1 emerges as a central hierarchical co-regulator in
spleen ontogeny (Fig. 7A). It will be of interest to determine
the roles of additional transcription factors required for spleen
development, such as Sox11 (Sock et al., 2004) and Nkx2.3
(Pabst et al., 1999; Wang et al., 2000; Tarlinton et al., 2003),
within the genetic pathways established by our study.
In conclusion, we demonstrate here the essential role of the
Pbx1-Hox11 transcriptional pathway in spleen ontogeny. We
provide evidence that Pbx1 is reiteratively required during
spleen development, as it is implicated, at least in part, in
splenic cell fate specification and morphogenesis, and then is
essential again, later in organogenesis, for anlage expansion
through control of progenitor cell proliferation. Finally, we
demonstrate that spleen ontogeny is dependent on the
orchestration of a complex network of transcription factors,
among which Pbx1 emerges as a central, master co-regulator.
Overall, our study takes a significant first step towards
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understanding the genetic and transcriptional control of spleen
development.
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